Japan Will Grapple With Mixed Reimbursement Policy In The Year Ahead
This article was originally published in PharmAsia News
Executive Summary
A Supreme court decision and TPP negotiations all point to further discussion around kongo shinryo – or mixed reimbursement – for treatments.